Clinical trial
A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma
NCT01842672 is registered in ClinicalTrials.gov with New York Medical College as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Mitoxantrone in Combination With Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) With Refractory/Relapsed Acute Leukemia or High Grade Non-Hodgkin Lymphoma
- Lead sponsor
- New York Medical College
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- September 30, 2022
- Enrollment
- 41 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, acute myelogenous leukemia, burkitt lymphoma/leukemia, diffuse large b-cell lymphoma, lymphoblastic lymphoma